• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人细胞上培养的全灭活猴免疫缺陷病毒疫苗无法预防在猴细胞上培养的同源猴免疫缺陷病毒。

Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.

作者信息

Putkonen P, Nilsson C, Hild K, Benthin R, Cranage M, Aubertin A M, Biberfeld G

机构信息

Department of Immunology, National Bacteriological Laboratory, Stockholm, Sweden.

出版信息

J Med Primatol. 1993 Feb-May;22(2-3):100-3.

PMID:8411101
Abstract

Several groups have reported protection against experimental SIV infection in macaques immunized with a whole inactivated virus vaccine. The aim of the current study was to investigate whether five macaques vaccinated with whole inactivated SIV and previously shown to be protected against challenge with two divergent strains of SIV grown on human cells could resist challenge with a subsequent homologous SIV grown on macaque cells. We show here that this same vaccine did not protect when the challenge virus was grown on primary cells of monkey origin.

摘要

有几个研究小组报告称,用全灭活病毒疫苗免疫的猕猴对实验性SIV感染具有保护作用。本研究的目的是调查五只接种了全灭活SIV疫苗且之前已证明对在人细胞上培养的两种不同SIV毒株的攻击具有抵抗力的猕猴,是否能够抵抗随后在猕猴细胞上培养的同源SIV的攻击。我们在此表明,当攻击病毒在猴源原代细胞上培养时,这种相同的疫苗没有起到保护作用。

相似文献

1
Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.在人细胞上培养的全灭活猴免疫缺陷病毒疫苗无法预防在猴细胞上培养的同源猴免疫缺陷病毒。
J Med Primatol. 1993 Feb-May;22(2-3):100-3.
2
Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.用来自HIV-2或SIV的病毒体衍生糖蛋白130进行免疫接种,可保护猕猴免受在人或猿猴细胞中培养或离体制备的攻击病毒的感染。
AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S27-32.
3
SIV vaccine protection of rhesus monkeys.
Biotechnol Ther. 1991;2(1-2):9-19.
4
Immunization of Macaca fascicularis with inactivated SIV preparations: challenge with human- or monkey-derived SIV and the effects of a longer immunization schedule.
J Med Primatol. 1993 Feb-May;22(2-3):110-8.
5
Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.用来自BK28分子克隆的灭活病毒免疫猕猴可预防SIV感染,但用BK28衍生的重组env和gag蛋白免疫则不能预防。
J Med Primatol. 1992 Feb-May;21(2-3):50-8.
6
SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques.被感染或接种疫苗的恒河猴产生的抗体所识别的猴免疫缺陷病毒包膜糖蛋白表位。
J Med Primatol. 1993 Feb-May;22(2-3):129-37.
7
SIV infection of macaques: a model for AIDS vaccine development.猕猴的猴免疫缺陷病毒感染:一种艾滋病疫苗开发的模型。
Dev Biol Stand. 1990;72:259-66.
8
Immunisation of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy.
J Med Primatol. 1993 Feb-May;22(2-3):104-9.
9
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
J Med Primatol. 1992 Feb-May;21(2-3):126-30.
10
Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
J Med Primatol. 1992 Feb-May;21(2-3):99-107.

引用本文的文献

1
Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.在艾滋病毒/艾滋病的猕猴模型中,HLA抗体介导的补体介导的病毒感染性中和作用与对SIV攻击的无菌免疫相关。
PLoS One. 2014 Feb 14;9(2):e88735. doi: 10.1371/journal.pone.0088735. eCollection 2014.
2
A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.一种用于检测针对感染 HIV-1 或 SIV 细胞的抗体依赖细胞介导的细胞毒性的新方法显示,与中和和结合测定中测量的抗体不完全重叠。
J Virol. 2012 Nov;86(22):12039-52. doi: 10.1128/JVI.01650-12. Epub 2012 Aug 29.
3
Current progress in the development of a prophylactic vaccine for HIV-1.HIV-1预防性疫苗研发的当前进展。
Drug Des Devel Ther. 2010 Dec 22;5:9-26. doi: 10.2147/DDDT.S6959.
4
Efficacy of AIDS vaccine strategies in nonhuman primates.艾滋病疫苗策略在非人灵长类动物中的疗效。
Med Microbiol Immunol. 2005 Aug;194(4):201-6. doi: 10.1007/s00430-005-0238-5. Epub 2005 Apr 21.
5
Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1.用含包膜、经甲醛处理、热灭活的1型人类免疫缺陷病毒进行疫苗接种后体液免疫反应的诱导。
J Virol. 2005 Apr;79(8):4927-35. doi: 10.1128/JVI.79.8.4927-4935.2005.
6
Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.减毒活猿猴免疫缺陷病毒疫苗可引发对1型人类免疫缺陷病毒嵌合病毒攻击的有效抵抗力。
J Virol. 1997 Nov;71(11):8141-8. doi: 10.1128/JVI.71.11.8141-8148.1997.
7
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.用HLA - DR免疫的猕猴可免受猿猴免疫缺陷病毒攻击。
J Virol. 1995 May;69(5):3117-24. doi: 10.1128/JVI.69.5.3117-3124.1995.